- Home
- SYRE vs SPH Comparison
SYRE vs SPH Comparison
Compare SYRE & SPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SYRE
- SPH
- Stock Information
- Founded
- SYRE 2013
- SPH 1945
- Country
- SYRE United States
- SPH United States
- Employees
- SYRE N/A
- SPH N/A
- Industry
- SYRE Biotechnology: Pharmaceutical Preparations
- SPH Other Specialty Stores
- Sector
- SYRE Health Care
- SPH Consumer Discretionary
- Exchange
- SYRE Nasdaq
- SPH Nasdaq
- Market Cap
- SYRE 1.1B
- SPH 1.2B
- IPO Year
- SYRE 2016
- SPH 1996
- Fundamental
- Price
- SYRE $16.23
- SPH $18.62
- Analyst Decision
- SYRE Strong Buy
- SPH
- Analyst Count
- SYRE 6
- SPH 0
- Target Price
- SYRE $57.60
- SPH N/A
- AVG Volume (30 Days)
- SYRE 681.2K
- SPH 105.5K
- Earning Date
- SYRE 11-06-2025
- SPH 11-13-2025
- Dividend Yield
- SYRE N/A
- SPH 6.94%
- EPS Growth
- SYRE N/A
- SPH N/A
- EPS
- SYRE N/A
- SPH 1.49
- Revenue
- SYRE N/A
- SPH $1,429,783,000.00
- Revenue This Year
- SYRE N/A
- SPH $10.99
- Revenue Next Year
- SYRE N/A
- SPH N/A
- P/E Ratio
- SYRE N/A
- SPH $12.59
- Revenue Growth
- SYRE N/A
- SPH 6.29
- 52 Week Low
- SYRE $10.91
- SPH $16.92
- 52 Week High
- SYRE $40.26
- SPH $22.24
- Technical
- Relative Strength Index (RSI)
- SYRE 52.04
- SPH 53.49
- Support Level
- SYRE $15.87
- SPH $18.37
- Resistance Level
- SYRE $17.18
- SPH $18.70
- Average True Range (ATR)
- SYRE 0.88
- SPH 0.27
- MACD
- SYRE 0.08
- SPH 0.00
- Stochastic Oscillator
- SYRE 70.65
- SPH 74.32
About SYRE Spyre Therapeutics Inc.
Spyre Therapeutics Inc is a biotechnology company that aims to create the next-generation of inflammatory bowel disease (IBD) products by combining antibody engineering, rational therapeutic combinations, and precision medicine approaches for patient selection. IBD is a chronic condition characterized by inflammation within the gastrointestinal tract, including two main disorders which are UC and CD. It has a single reportable segment, which is the development of biopharmaceutical products for the treatment of patients with IBD and other immune-mediated disease.
About SPH Suburban Propane Partners L.P.
Suburban Propane Partners LP distributes propane, fuel oil, and other refined fuels to customers in the East Coast and West Coast regions of the United States. Other operations include natural gas and electricity marketing in the deregulated New York and Pennsylvania markets. The company operates in three segments: Propane; Fuel Oil and Refined Fuels; and Natural Gas and Electricity. It generates maximum revenue from Propane segment.